7 hours Intellia Therapeutics, Inc. (NASDAQ:NTLA) to Post Q1 2025 Earnings of ($1.48) Per Share, Zacks Research Forecasts MarketBeat
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) – Stock analysts at Zacks Research cut their Q1 2025 earnings estimates for shares of Intellia Therapeutics in a research note issued to investors on Thursday, October 3rd. Zacks Research analy…
Earnings · Nasdaq 100 · Science